Central venous catheter-related thrombosis: A systematic review.

Journal of Infusion Nursing

Volumn 31, Issue 4, 2008, Pages 241-248

  Yacopetti, Nicholas ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ENOXAPARIN; HEPARIN; PROTAMINE SULFATE; WARFARIN; XIMELAGATRAN; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

ANTICOAGULANT THERAPY; BLEEDING; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; CHRONIC VEIN INSUFFICIENCY; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; DIAGNOSTIC ACCURACY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EMBOLECTOMY; HUMAN; INCIDENCE; LOW DRUG DOSE; LUNG EMBOLISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT DURATION; VENA CAVA FILTER; CENTRAL VENOUS CATHETERIZATION; MORTALITY;

ANTICOAGULANTS; CATHETERIZATION, CENTRAL VENOUS; FIBRINOLYTIC AGENTS; HUMANS; INCIDENCE; RISK FACTORS; THROMBOSIS;

EID: 53449086248     PISSN: 15331458     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.NAN.0000326833.59655.9e     Document Type: Review

References (69)

1. Sutera S. The history of Poiseuille's law. Annu Rev Fluid Mech. 1993;25:1-19.
2. Monreal M, Devant E. Thrombotic complications of central venous catheters in cancer patients. Acta Haematol. 2001;106:69-72.
3. Agnelli G, Verso M. Therapy insight: venous-catheter-related thrombosis in cancer patients. Nat Clin Pract Oncol. 2006;3(4):214-222.
4. Camara D. Minimizing risks associated with peripherally inserted central catheters in the NICU. Am J Matern Child Nurs. 2001;26(1):17-22.
5. Cesaro S. Anticoagulation prophylaxis for CVC-related thrombosis. Proceedings of the MASCC/ISOO 16th International Symposium, Supportive Care in Cancer; Miami Beach, Florida; June 2004.
6. Hadaway L. Major thrombotic and non-thrombotic complications: loss of patency. J Intravenous Nurs. 1998;21(suppl 5): S143-S160.
7. Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol. 2003;21(19):3665-3675. http://www.jco.org. Accessed May 16, 2006.
8. Van Rooden C, Rosendaal F, Meinders A, Van Oostayen JA, Van Der Meer FJ, Huisman MV The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis. Haematologica. 2004; 89(2):201-206.
9. Carr K. Physician compliance with warfarin prophylaxis for central venous catheters in patients with solid tumors. J Clin Oncol. 2000;18(21):3665-3667.
10. Couban S, Goodyear M, Burnell M, et al. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol. 2004;23(18):4063-4069.
11. Kuter D. Thrombotic complications of central venous catheters in cancer patients. Oncologist. 2004;9:207-216. http://www.TheOncologist.com. Accessed November 20, 2006.
12. Ong B, Gibbs H, Catchpole I, Hetherington R, Harper J. Peripherally inserted central catheters and upper extremity deep vein thrombosis. Austral Radiol. 2006;50:451-454.
13. Ratcliffe M, Broadfoot C, Davidson M, Kelly KF, Greaves M. Thrombosis, markers of thrombotic risk, indwelling central venous catheters and antithrombotic prophylaxis using low-dose warfarin in subjects with malignant disease. Clin Lab Haematol. 1999;21:353-357.
14. Allen A, Megargell J, Brown D, et al. Venus thrombosis associated with the placement of peripherally inserted central catheters. J Vascular Interv Radiol. 2000;11:1309-1134.
15. Shea C, Chang G, Rahimi R, Mahdavian M. The incidence of symptomatic, PICC-related venous thrombosis in hospitalized patients with inflammatory bowel disease: 1180. Am J Gastroenterol. 2006;101S:S460.
16. De Cicco M, Matovic M, Balestreri L, et al. Central venous thrombosis: an early and frequent complication in cancer patients bearing long term silastic catheter. A prospective study. Thromb Res. 1997;86(2):101-113.
17. Shah P, Shah V. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database Syst Rev. 2005;2. http://ovidsp.tx.ovid.com/ spb/ovidweb.cgi.
18. Timsit J, Farkas J, Boyer J, et al. Central vein catheter-related thrombosis in intensive care patients: incidence, risk factors, and relationship with catheter-related sepsis. Chest. 1998;114:207-213.
19. Cortelezzi A, Fracchiolla N, Maisonneuve P, et al. Central venous catheter-related complications in patients with haematological malignancies: a retrospective analysis of risk factors and prophylactic measures. Leuk Lymphoma. 2003;44(9):1495-1501.
20. Cortelezzi A, Moia M, Falanga A, et al. Incidence of thrombotic complications in patients with hematological malignancies with central venous catheters: a prospective multi-centre study. Br J Haematol. 2005;129:811-817.
21. Penney-Timmons E, Sevedge S. Outcome data for peripherally inserted central catheters used in an acute care setting. J Infus Nurs. 2004;27(6):431-436.
22. Moureau N, Poole S, Murdock M, Gray S, Semba C. Central venous catheters in home infusion care: outcomes analysis in 50, 470 patients. J Vasc Interv Radiol. 2002;13(10):1009-1015.
23. Andtbacka R, Babiera G, Singletary E, et al. Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery treated according to clinical pathways. Ann Surg. 2006;243:96-101.
24. Barclay L. Heparin not helpful for thrombosis prophylaxis related to central venous catheter. Arch Intern Med. 2003;163:1913-1921.
25. Geerts W, Pineo G, Heit J, et al. Prevention of venous thromboembolism. Chest. 2004;26(3):338S-400S. http://www.chestjournal.org. Accessed July 21, 2006.
26. Hadaway L. Keeping catheters clear with low-dose warfarin. Nursing 2004. 2004;73. http://www.nursing2004.com.
27. Joffe H, Kucher N, Tapson V, Goldhaber S. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation: J Am Heart Assoc. 2004;1605-1611. http://circulationaha.org. Accessed December 20, 2006. (Pubitemid 39297983)
28. King M, Rasnake M, Rodriguez R, Riely NJ, Stamm JA. Peripherally inserted central venous catheter-associated thrombosis: retrospective analysis of clinical risk factors in adult patients. South Med J. 2006;99(10):1073-1077.
29. Lee A, Levine M, Butler G, et al. Incidence, risk factors and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol. 2006;24(9):1404-1408.
30. Otten T, Stein P, Patel K, Mustafa S, Silbergleit A. Thromboembolic disease involving the superior vena cava and brachiocephalic veins. Chest. 2003;123(3):809-812.
31. Prandoni P, Bernardi E. Upper extremity deep thrombosis. Curr Opin Pulm Med. 1999;5(4):222-226.
32. Davidson B. Controversies in pulmonary embolism and deep venous thrombosis. Am Fam Physician. 1999;60:1969-1980.
33. Bona R. Central line thrombosis in patients with cancer. Curr Opin Pulm Med. 2003;9(5):364-366.
34. Mayo D. Catheter-related thrombosis. J Intraven Nurs. 2001;24(3S): S13-S22.
35. Racadio JM, Doellman DA, Johnson ND, Bean JA, Jacobs BR. Pediatric peripherally inserted central catheters: complication rates related to catheter tip location. Pediatrics. 2001;107(2):28-32. http://www.pediatrics.org/cgi/ content/full/107/2/e28. Accessed November 20, 2006.
36. Ascher E, Salles-Cunha S, Hingorani A. Morbidity and mortality associated with internal jugular vein thrombosis. Vasc Endovasc Surg. 2005;39(4):335-339.
37. Heaton D, Hann D, Inder A. Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis. Intern Med J. 2002;32:84-88.
38. Male C, Chait P, Andrew M. Central venous line-related thrombosis in children: association with central venous line location and insertion technique. Blood. 2003;101(11):4273-4278.
39. Grove R, Pevec W. Venous thrombosis related to peripherally inserted central catheters. J Vasc Intervent Radiol. 2000;11:837-840.
40. Gelfand E, Piazza G, Goldhaber S. Venous thromboembolism guidebook. Crit Pathw Cardiol. 2002;1(1):26-43.
41. Bartley M. Keep venous thromboembolism at bay. Nursing 2006. 2006;36(10):36-42. http://www.nursing2006.com. Accessed January 12, 2007.
42. Aggeli C, Brili S, Frogoudaki A, Barbetseas J, Stafanadis C. Four-month warfarin therapy results in a dissolution of a superior vena cava thrombus. Echocardiogr: JCV Ultrasound Allied Technol. 2004;21(5):435-436.
43. Abdullah B, Mohammad N, Sangkar J, et al. Incidence of upper limb venous thrombosis associated with peripherally inserted central catheters. Br J Radiol. 2005;78:569-600.
44. Gaitini D, Beck-Razi N, Brenner B. Prevalence of upper extremity deep venous thrombosis diagnosed by color Doppler duplex sonography in cancer patients with central venous catheters. J Ultrasound Med. 2006;25:1297-1303.
45. Klerk C, Smorenburg S, Buller H. Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review. Arch Intern Med. 2003;163(16):1913-1921.
46. Fijnheer R, Paijamsn B, Verdonck L, Nieuwenhuis HK, Roest M, Dekker AW. Factor V Leiden in central venous catheter-associated thrombosis. Brit J Haematol. 2002;118:267-270.
47. Kenney B, David M, Bensoussan A. Anticoagulation without catheter removal in children with catheter-related central vein thrombosis. J Pediatr Surg. 2004;31(6):816-818.
48. Di Nisio M, Middeldorp S, Buller H. Direct thrombin inhibitors. N Engl J Med. 2005;353:1028-1040.
49. Seigel E, Jew A, Delcore R, Iliopoulos J, Thomas J. Thrombotic therapy for catheter-related thrombosis. Am J Surg. 1993;166 (6):716-718.
50. Chaitowitz I, Heng R, Bell K. Managing peripherally inserted central catheter-related venous thrombosis: how I do it. Australas Radiol. 2006;50:132-135.
51. Volkow P, Cornejo-Juarez P, Arizpe-Bravo A, Garcia-Mendez J, Baltazares-Lipp E, Perez-Padilla R. Catheter-related septic thrombophlebitis of the great central veins successfully treated with low-dose streptokinase thrombolysis and antimicrobials. Thromb J. 2005;3:11. http://www. thrombosisjournal.com/content/3/1/11. Accessed November 30, 2006.
52. Chemaly R, de Parres J, Rehm S, et al. Venous thrombosis associated with peripherally inserted central catheters: a retrospective analysis of the Cleveland clinical experience. Clin Infect Dis. 2002;34:1179-1183.
53. Eastman M, Khorsand M, Maki D, et al. Central venous device-related infections and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2. Cancer. 2001;9(4):806-814.
54. Kuriakose P, Colon-Otero G, Paz-Fumagalli R. Risk of deep venous thrombosis associated with chest versus arm central venous subcutaneous port catheters: a 5-year single-institution retrospective study. J Vasc Interv Radiol. 2002;13(2):179-184.
55. Ngo A, Murphy S. A theory-based intervention to improve nurses' knowledge, self-efficacy, and skills to reduce PICC occlusion. J Infus Nurs. 2005;28(3):173-181.
56. Mehall J, Saltzman D, Jackson R, Smith S. Fibrin sheath enhances central venous catheter infection. Crit Care Med. 2002; 30(4):908-912.
57. Aggarwal S, McCauley W. Tunnelled central venous catheter-induced thrombosis: a rare case of superior vena cava syndrome. Am J Emerg Med. 2005;7(4):273-277.
58. Hong A, Cook D, Sigouin C, Warkentin T. Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia. Blood. 2003; 101(8):3049-3051.
59. Caprini J, Arcelus J, et al. State-of-the-art venous thromboembolism prophylaxis. Scope. 2001;8:228-240.
60. Rosen M, Latto I, Ng W. Handbook of Percutaneous Central Venous Catheterization. London, UK: WB Saunders; 1981:167.
61. Taylor M. A fascination with phlebitis. J Vasc Access Device. 2000;5(3):24-28.
62. Climo M, Diekema D, Warren D, et al. Prevalence of the use of central venous access devices within and outside of the intensive care unit: results of a survey among hospitals in the prevention epicenter program of the Centers for Disease Control and Prevention. Infect Control Hosp Epidemiol. 2003;24(12):942-945.
63. Fletcher J, MacLellan D, Fisher C, et al. Prevention of Venous Thromboembolism: Best Practice Guidelines for Australia and New Zealand. 2nd ed. Sydney, New South Wales, Australia: Health Education and Management International; 2001.
64. Renner C. Polyurethane vs. silicone PICC catheters: a brief review of characteristics and clinical outcomes. J Vasc Access Devices. 1998;3(1):16-21.
65. Seeley M, Santiago M, Shott S. Prediction tool for thrombi associated with peripherally inserted central catheters. J Infus Nurs. 2007;30(5):280-286.
66. Van Weerts H, Dolan G, Wichers I, De Vries C, Ter Riet G, Buller H. Spontaneous superficial venous thrombophlebitis: does it increase risk for thromboembolism? A historic follow-up study in primary care. J Fam Pract. 2006;55(1):52-57.
67. Neher J, Safranek S. What is the best therapy for superficial thrombophlebitis? Clinical inquiries. J Fam Pract. 2004;55(7):583-585.
68. Antman E, Bennett J, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of nonsteroidal anti-inflammatory drugs. An update for clinicians. A scientific statement from the American Heart Association. Circulation. 2007;115:1634-1642. http://www. circulationaha.org. Accessed December 1, 2007.
69. Levin A, Rocco M, Eknoyan G, Levin N. National Kidney Foundations Kidney Disease Outcome Quality Initiative 2006. http://www.kidney.org/professionals/ kdoqi/guideline-upHD-PD-VA/va-guide1.htm. Accessed February 4, 2007.